ONPH (Oncology Pharma) Gross Margin %: 0.00% (As of Dec. 2004)


What is Oncology Pharma Gross Margin %?

Oncology Pharma ONPH -24.29% Gross Margin % is 0.00% as of Dec. 2004.

Gross Margin % is calculated as gross profit divided by its revenue. Oncology Pharma's Gross Profit for the three months ended in Dec. 2004 was $0.00 Mil. Oncology Pharma's Revenue for the three months ended in Dec. 2004 was $0.00 Mil. Therefore, Oncology Pharma's Gross Margin % for the quarter that ended in Dec. 2004 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Oncology Pharma's Gross Margin % or its related term are showing as below:


ONPH's Gross Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 42.14
* Ranked among companies with meaningful Gross Margin % only.

Oncology Pharma had a gross margin of N/A% for the quarter that ended in Dec. 2004 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Oncology Pharma was 0.00% per year.

Oncology Pharma  (OTCPK:ONPH) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Oncology Pharma had a gross margin of N/A% for the quarter that ended in Dec. 2004 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Oncology Pharma Gross Margin % Related Terms

Oncology Pharma Gross Margin % Historical Data

* Premium members only.

The historical data trend for Oncology Pharma's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncology Pharma Gross Margin % Chart

Oncology Pharma Annual Data
Trend Jun96 Jun97 Jun98 Mar00 Mar01 Mar02 Mar03
Gross Margin %
Get a 7-Day Free Trial 29.93 67.67 66.67 63.02 63.05

Oncology Pharma Quarterly Data
Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.79 69.15 0.00 0.00 0.00

ONPH vs TAUG, IMUN, TNTY: Gross Margin % Comparison

For the Shell Companies subindustry, Oncology Pharma's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncology Pharma Gross Margin % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Oncology Pharma's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Oncology Pharma's Gross Margin % falls into.


Oncology Pharma Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Oncology Pharma's Gross Margin for the fiscal year that ended in Mar. 2003 is calculated as

Gross Margin % (A: Mar. 2003 )=Gross Profit (A: Mar. 2003 ) / Revenue (A: Mar. 2003 )
=2.1 / 3.28
=(Revenue - Cost of Goods Sold) / Revenue
=(3.28 - 1.212) / 3.28
=63.05 %

Oncology Pharma's Gross Margin for the quarter that ended in Dec. 2004 is calculated as


Gross Margin % (Q: Dec. 2004 )=Gross Profit (Q: Dec. 2004 ) / Revenue (Q: Dec. 2004 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
Oncology Pharma (ONPH) has a Gross Margin % of 0.00% as of Dec. 2004. Gross margin is the ratio of total gross profit to net sales. View historical data on Oncology Pharma and its competitors.
Is Oncology Pharma's Gross Margin % too high?
Oncology Pharma's current Gross Margin % is 0.00%.
How does Oncology Pharma's Gross Margin % compare to TAUG and IMUN?
Oncology Pharma's Gross Margin % of 0.00% can be compared against companies in the Diversified Financial Services industry. The industry median Gross Margin % is 42.14. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Diversified Financial Services company?
The median Gross Margin % among Diversified Financial Services companies is 42.14, based on 73 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Oncology Pharma and its competitors. For the Diversified Financial Services industry, the median Gross Margin % is 42.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oncology Pharma's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncology Pharma stock overvalued right now?
Oncology Pharma (ONPH) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Oncology Pharma (ONPH), the current Gross Margin % is 0.00% as of Dec. 2004. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncology Pharma Business Description

Address 732 S 6TH Street, Suite R, Las Vegas, NV, USA, 89101
Oncology Pharma Inc is a shell company and currently has no operations.